Acting Rapidly – Step 2 in Hypertension Control Webinar
Last Modified | December 10, 2024 |
Audience | Healthcare Professionals | |
Topics | Act Rapidly | |
Resource Type | Video / Webinar |
Languages | english |
Formats |
Coming Soon
The Act Rapidly webinar will be available shortly as an enduring continuing education activity with credit available for physicians, physician assistants, nurse practitioners, nurses, pharmacists, and other health professionals. In the meantime, the recording can be viewed here on demand.
Description
This one-hour webinar was designed to train clinicians and care teams in the “Act Rapidly” component of the AMA MAP™ framework. MAP stands for Measure Accurately, Act Rapidly, and Partner with Patients.
The goal of acting rapidly is to reduce therapeutic inertia and improve blood pressure in patients whose BP is uncontrolled. This is accomplished through a combination of using an evidence-based treatment protocol, using single-pill combination antihypertensive medications, team-based care, and following up frequently with patients until BP control is achieved. The activity will include didactic instruction, interactive elements to apply learning, and practical tools and resources to assess and improve practice presented from a team-based perspective.
Learning Objectives
At the completion of this course, the learner will be able to:
- Define therapeutic inertia and list contributing factors
- Describe impact and importance of treatment intensification, follow-up interval, and medication adherence strategies on improving blood pressure control
- Review strategies and resources to address therapeutic inertia and increase treatment intensification, including the use of combination antihypertensive medications
Faculty
Kate Kirley, MD, Director Chronic Disease Prevention And Programs
Improving Health Outcome, American Medical Association
Klodiana Myftari, PharmD, Clinical Pharmacy Relations Director
Improving Health Outcome, American Medical Association
Alison Smith, MPH, BA, BSN, RN, Program Director, Target: BP
American Heart Association / American Medical Association